Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Current Opinion in Urology|March 2, 2013
The economics of active surveillance for prostate cancerMarc A Dall'EraCurrent Opinion in Urology|February 19, 2015
Patient and disease factors affecting the choice and adherence to active surveillanceMarc A Dall'EraEuropean Urology Focus|July 21, 2017
Clinical Case Discussion: Intermediate-risk Prostate Cancer: The Case for Active SurveillanceMarc A Dall'Era, Benjamin J DaviesBJU International|February 12, 2019
Use of multiparametric magnetic resonance imaging in prostate cancer active surveillanceAllison S Glass, Marc A Dall'EraThescientificworldjournal|December 21, 2010
Active surveillance for localized prostate cancer--current practices and recommendationsJennifer N Wu, Marc A Dall'EraCurrent Urology Reports|September 4, 2008
Watchful waiting versus active surveillance: appropriate patient selectionMarc A Dall'Era, Christopher J KaneNature Clinical Practice. Urology|February 21, 2008
Active surveillance for low-risk prostate cancer: selection of patients and predictors of progressionMarc A Dall'Era, Badrinath R KonetyCurrent Opinion in Urology|March 20, 2009
Outcomes and follow-up strategies for patients on active surveillanceMarc A Dall'Era, Peter R CarrollTranslational Andrology and Urology|May 8, 2018
Indications for and transitioning to secondary treatment while on active surveillance for prostate cancerAllison S Glass, Marc A Dall'EraCurrent Opinion in Urology|March 6, 2012
Economic analysis of active surveillance for localized prostate cancerSun Kim, Marc A Dall'Era, Christopher P EvansPageof 7